From Prediction to Prescription: When AI Stops Forecasting and Starts Deciding
Tracy Thayne7/2/2026·7 min read
I once sat in a quarterly review where a data scientist presented a genuinely impressive churn model. It predicted, with real accuracy, which accounts were most likely to leave in the next ninety days. The room nodded. Someone said "great work." The slide advanced. And then nothing happened. No one was assigned to the at-risk accounts, no play was triggered, no budget moved. A quarter later, most of the accounts the model flagged had churned, exactly as forecast, and we had watched it happen with perfect foresight and zero action. The prediction was correct. It was also useless, because a forecast that does not change a decision is just a more expensive way to be surprised on schedule.
That gap, between knowing what will happen and doing something about it, is the real frontier of AI in 2026, and the market is finally crossing it. The conversation is moving from prediction to prescription: from systems that forecast an outcome to systems that recommend the move, and increasingly take it. Gartner predicts that at least 15% of day-to-day work decisions will be made autonomously through agentic AI by 2028, up from 0% in 2024, and that a third of enterprise applications will include agentic AI by then. In customer service alone, Gartner expectsagentic AI to autonomously resolve 80% of common issues by 2029, cutting operational costs by 30%. As one CIO put it plainly, predicting the future is the easy part. Deciding what to do is where the value, and the difficulty, actually lives.
Prediction Was Never the Bottleneck
We have been good at forecasting for years. We were just bad at acting on it.
The analytics era gave marketing an abundance of prediction: lead scores, propensity models, churn risk, forecast pipelines. The dashboards multiplied, and the foresight got sharper. What never improved at the same rate was the distance between the insight and the action. A prediction lands on a screen, a human has to notice it, interpret it, decide whether to trust it, figure out the right response, and then actually do the work, usually across three other tools. By the time all of that happens, the window has often closed. The bottleneck in AI was never the quality of the forecast. It was the human relay race between the forecast and the move.
Subscribe
Get notified by email when we publish a new post. No spam, unsubscribe anytime.
Prescription collapses that relay. Instead of telling you an account is at risk, a prescriptive system tells you what to do about it, and an agentic one does it: triggers the play, drafts the outreach, reallocates the spend. That is the leap that turns analytics from a reporting function into an operating one.
Prescription Is the Step Most Tools Skipped
It helps to be precise about the ladder, because vendors blur it constantly.
Descriptive analytics tells you what happened. Predictive analytics tells you what is likely to happen next. Prescriptive analytics tells you what to do about it, and agentic systems take the further step of acting on the recommendation and learning from the result. Most marketing tooling has lived on the first two rungs for a decade. The reason the top rungs stayed empty is not that nobody wanted them. It is that recommending a good move requires something predicting an outcome does not: a deep, current understanding of your specific business. A forecast can be made from patterns in the data. A good prescription has to know your customers, your constraints, your past decisions, and what actually worked the last three times you faced this, or its advice is generic and you should not follow it.
Prescription Without Context Is Confident Guessing
This is exactly where the wave will break for most companies, and the warning signs are already in the data.
Gartner also predicts that over 40% of agentic AI projects will be canceled by the end of 2027, citing escalating costs, unclear value, and inadequate risk controls. Read that next to the autonomy numbers and the real story emerges: the appetite for prescription is enormous, and the failure rate is about to be enormous too. The projects that fail will not fail because the models are weak. They will fail because a system was asked to prescribe and act inside a business it did not actually understand. A prescription is only as good as the context behind it. Strip the context away and "what you should do" is just a confident guess with an automation budget attached, which is more dangerous than no recommendation at all, because now it executes.
I have made the version of this argument about output and about returns. In Why Most Companies Are Getting AI ROI Wrong I argued that value shows up when AI changes a decision, not when it accelerates a task. Prescription is that idea taken to its conclusion: the whole point is to change the decision. But you cannot trust a machine to change a decision in your business unless it can see your business, which is the thesis I keep returning to in Context Is the Whole Game. Context is what separates a prescription you can act on from one you have to second-guess, and second-guessing every recommendation puts the human relay race right back in the middle.
Action Raises the Stakes, So the Context Has to Be Real
Prediction is low-risk because a human still decides. Prescription that acts removes the human, and that changes everything.
When a forecast is wrong, you ignore it. When an autonomous system acts on a bad prescription, it has already moved the budget, sent the email, or reprioritized the queue before anyone reviews it. The faster and more autonomous the system, the more it matters that the context underneath it is complete, current, and coherent. This is the operating discipline behind agentic marketing that I described in earlier writing on the orchestrator role: the marketer's job shifts from doing the work to governing a system that acts, and you cannot govern what is reasoning from a fragmented, out-of-date picture of your own company. The reward for getting it right is real, the 80% resolution and 30% cost numbers are not small, but they are only available to teams whose context is solid enough to act on. Everyone else gets the cancellation statistic.
What to Do Before You Trust a Prescription
You earn the right to autonomy. You do not buy it.
Before you let a system prescribe, let alone act, run two checks. First, audit the context it will reason from: can it actually reach your customer history, your past campaign results, your product detail, your real constraints, in a current and usable form, or is it reasoning from a stale slice. If the context is thin, fix that before you turn on autonomy, because a prescription on thin context is a liability. Second, start with reversible decisions. Let the system prescribe and act where a wrong move is cheap to undo, watch whether its recommendations would have been the ones you would have made, and expand its authority only as it earns trust. As I argued in What Is Operational Intelligence, the value was always in connected intelligence driving decisions, not in another report. Prescription is where that finally pays off, but only on a context layer rich enough to deserve the trust.
The Takeaway
The era of prediction taught us to forecast beautifully and act slowly. Prescription closes that gap by moving from "here is what will happen" to "here is what to do," and agentic systems take the last step and do it. That is a genuine leap, and the demand for it is about to collide with a failure rate just as large, because most companies will ask AI to prescribe inside a business it cannot see.
The dividing line is context. A prescription is only as trustworthy as the understanding behind it, and an action is only as safe as the context that triggered it. The teams that win the prescriptive era will not be the ones with the boldest automation. They will be the ones that built a context layer real enough to act on, then let the system decide where the cost of being wrong was low and the proof of being right kept compounding.
If you want the weekly take on context, AI, and the operating model of the next decade, subscribe to the blog (below).
Tracy Thayne* is the founder of Expona, an AI-powered operational intelligence platform for B2B marketing. Read the Expona founder story or subscribe to the blog (below) for weekly insights on context, AI, and the operating model of the next decade.*
